These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A long-term study of regression of precancerous lesions under oral progestin medication: observations on the prevalence of carcinoma in situ and dysplasia in private versus planned parenthood groups.
    Author: Ayre JE, Reyner FC, Leguerrier JM, Schwartz R.
    Journal: Cancer Cytol; 1971; 11(1):39-48. PubMed ID: 12276202.
    Abstract:
    This study is concerned with the relationship of the oral progestins to cancer of the cervix and endometrium and to establish the effect of long-term use of the pill on lesions of carcinoma in situ or dysplasia. A screening study was made of 1696 women attending the Nassau County Planned Parenthood Clinic. Patients with negative cytology were advised to have a routine check in 6 to 12 months. Those with positive cytology who were also found to have advanced or progressive lesions were referred for surgical treatment. Patients showing cells of moderate dysplasia or carcinoma in situ were referred to the Cancer Prevention Clinic where they could elect immediate surgical treatment or experimental treatment with an oral contraceptive. Almost all, 68 in number, chose to defer surgery. They visited the clinic at 4 to 6 week intervals when an examination, a Paanicolaou smear and fluorescent microscopic DNA of nuclear patterna were done. While under study no premalignant lesion progressed to a stage of infiltration. Clinically none showed lesions suggestive of early cancer. Of this group 45 showed no alteration in growth, of cells while 21 had signs of regression, some to a normal morphology. Progression occurred in 2 patients. Of these 1 followed a 4 month interval without oral progestin medication. The greater prevalence of positive findings in patients attending Planned Parenthood Clinics as compared with those being treated by private practitioners is attributed to the types of patients being tested. The clinics see mostly patients of lower socioeconomic status, those who have been more sexually active and those who have begun sexual activities at an early age with more sexual partners. These findings are consistent with the theory of viral transmission of cancer of the cervix by sexual intercourse. After over 8 years of study the authors conclude that the pill does not initiate or accelerate precancerous growth but that the oral progestins at high dose levels show some cancer-inhibiting or regressive influences, often dramatic. Al so they think that the existence of dysplasia or cancer in situ in women attending clinics antedates the taking of the pill, perhaps by several years.
    [Abstract] [Full Text] [Related] [New Search]